Skip to content

Study of partial femoral head replacement prosthesis and clinical application for hip preservation

Study of partial femoral head replacement prosthesis and clinical application for hip preservation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091082
Enrollment
Unknown
Registered
2024-10-21
Start date
2024-10-21
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Necrosis of femoral head

Interventions

Pilot group (retrospective):Intervention through partial femoral head replacement: after anesthesia took effect, the patient was fixed in the lateral position on the operating bed, and the Hardinge ap

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of necrosis of femoral head, significant pain in the hip joint, and poor results of conservative treatment; 2. Age 18-65 years old; 3.The extent of necrosis of femoral head does not exceed 50% of the volume of the femoral head; 4. ARCO staging of necrosis of femoral head is stage II or III, without acetabular side involvement and degeneration.

Exclusion criteria

Exclusion criteria: 1. acetabular side cartilage wear and osteoarthritis; 2. hip rheumatoid arthritis and other inflammatory arthropathy involving the whole joint; 3. hip dysplasia; 4. hip dislocation or subluxation; 5. neuromuscular system lesions, quadriceps muscle strength disorders, etc.; 6. the patient's general condition is poor, cardiorespiratory failure, and other reasons can not tolerate the operation.

Design outcomes

Primary

MeasureTime frame
Harris score;VAS;

Secondary

MeasureTime frame
ROM;complications;forgotten joint score,FJS;36-item Short-Form,SF-36;

Countries

China

Contacts

Public ContactZhang Qidong

China-Japan Friendship Hospital

18901078608@163.com+86 189 0107 8608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026